Updat3
Search
Sign in

India's HPV campaign delivers 80 lakh doses since Feb 2026; Uttar Pradesh leads, Gujarat and Mizoram 100%

Topic: healthRegion: AsiaUpdated: i2 outletsSources: 3Spectrum: Mostly Center2 min read
📰 Scored from 2 outletsacross 1 Left 1 Center How we score bias →
Story Summary
SITUATION
India's national HPV vaccination campaign has given 80 lakh doses since its launch in Feb 2026, providing free, voluntary single-dose shots to 14-year-old girls at government health facilities with parental consent. Uttar Pradesh has administered over 22 lakh doses, Gujarat and Mizoram have reached 100% coverage, and about 1.2 crore girls are expected to be eligible.
Coveragetap to expand ▾
Spectrum: Mostly Center🌍Asia: 1 · Other: 1
Political Spectrum
Position is inferred from coverage mix.
i2 outlets · Center
Left
Center
Right
Left: 1
Center: 1
Right: 0
Geography Coverage
Distribution of where coverage is coming from.
i2 unique outlets · Dominant: Asia
KEY FACTS
  • India launched a national HPV vaccination campaign in Feb 2026 offering free, voluntary single-dose shots to 14-year-old girls with parental consent at government health facilities.
  • The campaign has delivered 80 lakh HPV vaccine doses since its launch.
  • Uttar Pradesh has administered over 22 lakh vaccinations—the highest number among states.
  • Gujarat and Mizoram have achieved 100% coverage of the target group.
  • Around 1.2 crore 14-year-old girls are expected to be eligible for the initiative.
  • Bihar and Assam have crossed 90% coverage; Karnataka is at 85%; Chhattisgarh, Sikkim, Kerala, Telangana and Odisha are at 60% coverage.
HISTORICAL CONTEXT

The immediate backdrop is the broader global instability that has affected medical supply chains since early 2026: after months of escalating tensions and attacks on regional targets, the United States and Israel launched coordinated military strikes against Iranian power plants, air defenses and military infrastructure in March 2026, and the resulting conflict has disrupted shipping, air freight and donor attention across multiple regions.

Structurally, the HPV rollout rests on long-standing global immunization frameworks: the World Health Organization’s Global Vaccine Action Plan endorsed by WHO member states in 2012 built national targets for adolescent immunization into global goals, and Gavi, the Vaccine Alliance, began funding HPV introduction in low- and middle-income countries after its Board decisions in the early 2010s to expand cervical cancer prevention.

Sources
3 of 3 linked articles